Avoro Capital Advisors LLC Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$7239.8T
Holdings
42
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APLSAPELLIS PHARMACEUTICALS INC | 11,111,111 | $665.1T | 9.19% | |
| 2 | UTHUNITED THERAPEUTICS CORP | 2,858,888 | $628.6T | 8.68% | |
| 3 | ASNDASCENDIS PHARMA | 3,755,555 | $473.0T | 6.53% | |
| 4 | ARGXARGENX SE | 1,234,567 | $469.7T | 6.49% | |
| 5 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,888,888 | $437.1T | 6.04% | |
| 6 | SRPTSAREPTA THERAPEUTICS INC | 4,344,444 | $418.9T | 5.79% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 4,300,000 | $414.6T | 5.73% | |
| 8 | XBISPDR SERIES TRUST - S&P BIOTECH | 4,444,444 | $396.8T | 5.48% | |
| 9 | AM6AMICUS THERAPEUTICS INC | 27,400,000 | $388.8T | 5.37% | |
| 10 | CERE1EURCEREVEL THERAPEUTICS HLDNG | 7,555,555 | $320.4T | 4.42% | |
| 11 | KRYSKRYSTAL BIOTECH INC | 2,565,555 | $318.3T | 4.40% | |
| 12 | MRTXEURMIRATI THERAPEUTICS INC | 4,886,840 | $287.1T | 3.97% | |
| 13 | CBAYUSDCYMABAY THERAPEUTICS INC | 11,111,111 | $262.4T | 3.63% | |
| 14 | XENEXENON PHARMACEUTICALS INC | 5,666,666 | $261.0T | 3.61% | |
| 15 | ALNYALNYLAM PHARMACEUTICALS INC | 1,111,111 | $212.7T | 2.94% | |
| 16 | ITCIEURINTRA-CELLULAR THERAPIES INC | 2,255,555 | $161.5T | 2.23% | |
| 17 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 2,580,000 | $155.8T | 2.15% | |
| 18 | KYMRKYMERA THERAPEUTICS INC | 3,775,000 | $96.1T | 1.33% | |
| 19 | GPCRSTRUCTURE THERAPEUTICS INC | 2,333,333 | $95.1T | 1.31% | |
| 20 | SNDXSYNDAX PHARMACEUTICALS INC | 4,222,222 | $91.2T | 1.26% | |
| 21 | BCRXBIOCRYST PHARMACEUTICALS INC | 13,050,000 | $78.2T | 1.08% | |
| 22 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,700,000 | $54.5T | 0.75% | |
| 23 | ROIVROIVANT SCIENCES LTD | 4,651,162 | $52.2T | 0.72% | |
| 24 | KURAKURA ONCOLOGY INC | 2,980,000 | $42.9T | 0.59% | |
| 25 | SYRESPYRE THERAPEUTICS INC | 1,839,138 | $39.6T | 0.55% | |
| 26 | KRTXKARUNA THERAPEUTICS INC | 125,000 | $39.6T | 0.55% | |
| 27 | RCKTROCKET PHARMACEUTICALS INC | 1,260,900 | $37.8T | 0.52% | |
| 28 | ARWRARROWHEAD PHARMACEUTICALS INC | 1,130,000 | $34.6T | 0.48% | |
| 29 | MRNS*MARINUS PHARMACEUTICALS INC | 3,150,000 | $34.2T | 0.47% | |
| 30 | MNKDMANNKIND CORP | 9,000,000 | $32.8T | 0.45% | |
| 31 | SLNOSOLENO THERAPEUTICS INC | 785,000 | $31.6T | 0.44% | |
| 32 | VRCAVERRICA PHARMACEUTICALS INC | 3,999,999 | $29.3T | 0.40% | |
| 33 | IMGNEURIMMUNOGEN INC | 875,000 | $25.9T | 0.36% | |
| 34 | GLUEMONTE ROSA THERAPEUTICS INC | 4,535,000 | $25.6T | 0.35% | |
| 35 | MRUSMERUS N V | 888,888 | $24.4T | 0.34% | |
| 36 | TRMLTOURMALINE BIO INC | 868,407 | $22.7T | 0.31% | |
| 37 | RNAAVIDITY BIOSCIENCES INC | 2,510,000 | $22.7T | 0.31% | |
| 38 | RAREULTRAGENYX PHARMACEUTICAL INC | 350,000 | $16.7T | 0.23% | |
| 39 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $13.5T | 0.19% | |
| 40 | NUVLNUVALENT INC | 178,921 | $13.2T | 0.18% | |
| 41 | TSHATAYSHA GENE THERAPIES INC | 4,355,555 | $7.7T | 0.11% | |
| 42 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $5.8T | 0.08% |